---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) August 19, 2004

 

---

 

Retractable Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

---

 

Texas		000-30885		75-2599762
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

511 Lobo Lane, Little Elm, Texas		75068-0009
(Address of principal executive offices)		(Zip Code)

 

Registrant’s telephone number, including area code (972) 294-1010

 

None

(Former name or former address, if changed since last report)

 

---

---

Item 5. Other Events and Regulation FD Disclosure.

 

On August 19, 2004, we issued a press release, a copy of which is attached hereto as Exhibit 99.1.

 

Item 7. Financial Statements and Exhibits.

 

(c)

Exhibits

 

99.1	Press release announcing award by U.S. government of safety syringe contract for Africa under global HIV/AIDS initiative

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DATE: August 19, 2004		RETRACTABLE TECHNOLOGIES, INC.
				(Registrant)
		BY:		/s/ THOMAS J. SHAW
				THOMAS J. SHAW
				PRESIDENT AND CHIEF EXECUTIVE OFFICER